Logo image of GLXG

GALAXY PAYROLL GROUP LTD (GLXG) Stock Fundamental Analysis

NASDAQ:GLXG - Nasdaq - VGG376921034 - Common Stock

1.22  -0.08 (-6.15%)

After market: 1.2106 -0.01 (-0.77%)

Fundamental Rating

4

Overall GLXG gets a fundamental rating of 4 out of 10. We evaluated GLXG against 82 industry peers in the Professional Services industry. Both the profitability and the financial health of GLXG get a neutral evaluation. Nothing too spectacular is happening here. GLXG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year GLXG was profitable.
GLXG had a positive operating cash flow in the past year.
GLXG Yearly Net Income VS EBIT VS OCF VS FCFGLXG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 5M 10M 15M 20M 25M

1.2 Ratios

With an excellent Return On Assets value of 28.70%, GLXG belongs to the best of the industry, outperforming 98.73% of the companies in the same industry.
Looking at the Return On Equity, with a value of 117.84%, GLXG belongs to the top of the industry, outperforming 97.47% of the companies in the same industry.
GLXG's Return On Invested Capital of 99.38% is amongst the best of the industry. GLXG outperforms 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for GLXG is significantly above the industry average of 13.48%.
The 3 year average ROIC (94.84%) for GLXG is below the current ROIC(99.38%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 28.7%
ROE 117.84%
ROIC 99.38%
ROA(3y)39.78%
ROA(5y)N/A
ROE(3y)106.85%
ROE(5y)N/A
ROIC(3y)94.84%
ROIC(5y)N/A
GLXG Yearly ROA, ROE, ROICGLXG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 50 100

1.3 Margins

The Profit Margin of GLXG (16.90%) is better than 88.61% of its industry peers.
In the last couple of years the Profit Margin of GLXG has declined.
GLXG has a Operating Margin of 21.41%. This is amongst the best in the industry. GLXG outperforms 88.61% of its industry peers.
In the last couple of years the Operating Margin of GLXG has declined.
With a decent Gross Margin value of 52.37%, GLXG is doing good in the industry, outperforming 62.03% of the companies in the same industry.
GLXG's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 21.41%
PM (TTM) 16.9%
GM 52.37%
OM growth 3Y-11.89%
OM growth 5YN/A
PM growth 3Y-13.11%
PM growth 5YN/A
GM growth 3Y-7.12%
GM growth 5YN/A
GLXG Yearly Profit, Operating, Gross MarginsGLXG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 20 40 60

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), GLXG is creating value.
GLXG has about the same amout of shares outstanding than it did 1 year ago.
There is no outstanding debt for GLXG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
GLXG Yearly Shares OutstandingGLXG Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M
GLXG Yearly Total Debt VS Total AssetsGLXG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

GLXG has an Altman-Z score of 8.29. This indicates that GLXG is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 8.29, GLXG belongs to the top of the industry, outperforming 93.67% of the companies in the same industry.
GLXG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.29
ROIC/WACC9.78
WACC10.16%
GLXG Yearly LT Debt VS Equity VS FCFGLXG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 5M 10M 15M

2.3 Liquidity

GLXG has a Current Ratio of 0.86. This is a bad value and indicates that GLXG is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.86, GLXG is not doing good in the industry: 84.81% of the companies in the same industry are doing better.
GLXG has a Quick Ratio of 0.86. This is a bad value and indicates that GLXG is not financially healthy enough and could expect problems in meeting its short term obligations.
GLXG's Quick ratio of 0.86 is on the low side compared to the rest of the industry. GLXG is outperformed by 83.54% of its industry peers.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.86
GLXG Yearly Current Assets VS Current LiabilitesGLXG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M

0

3. Growth

3.1 Past

GLXG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.64%.
Measured over the past years, GLXG shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.18% on average per year.
The Revenue has decreased by -4.07% in the past year.
The Revenue has been decreasing by -4.68% on average over the past years.
EPS 1Y (TTM)-38.64%
EPS 3Y-17.18%
EPS 5YN/A
EPS Q2Q%-38.9%
Revenue 1Y (TTM)-4.07%
Revenue growth 3Y-4.68%
Revenue growth 5YN/A
Sales Q2Q%-4.26%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GLXG Yearly Revenue VS EstimatesGLXG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 10M 20M 30M 40M
GLXG Yearly EPS VS EstimatesGLXG Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024

2

4. Valuation

4.1 Price/Earnings Ratio

GLXG is valuated rather expensively with a Price/Earnings ratio of 20.33.
The rest of the industry has a similar Price/Earnings ratio as GLXG.
Compared to an average S&P500 Price/Earnings ratio of 27.96, GLXG is valued a bit cheaper.
Industry RankSector Rank
PE 20.33
Fwd PE N/A
GLXG Price Earnings VS Forward Price EarningsGLXG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GLXG is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of GLXG is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 26.02
EV/EBITDA 16.64
GLXG Per share dataGLXG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.1 0.2 0.3

4.3 Compensation for Growth

The decent profitability rating of GLXG may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for GLXG!.
Industry RankSector Rank
Dividend Yield N/A

GALAXY PAYROLL GROUP LTD

NASDAQ:GLXG (1/17/2025, 8:04:12 PM)

After market: 1.2106 -0.01 (-0.77%)

1.22

-0.08 (-6.15%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap22.28M
AnalystsN/A
Price TargetN/A
Short Float %2.85%
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 20.33
Fwd PE N/A
P/S 3.84
P/FCF 26.02
P/OCF 25.79
P/B 26.79
P/tB 26.79
EV/EBITDA 16.64
EPS(TTM)0.06
EY4.92%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.05
FCFY3.84%
OCF(TTM)0.05
OCFY3.88%
SpS0.32
BVpS0.05
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 28.7%
ROE 117.84%
ROCE 125.14%
ROIC 99.38%
ROICexc N/A
ROICexgc N/A
OM 21.41%
PM (TTM) 16.9%
GM 52.37%
FCFM 14.77%
ROA(3y)39.78%
ROA(5y)N/A
ROE(3y)106.85%
ROE(5y)N/A
ROIC(3y)94.84%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)119.42%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-11.89%
OM growth 5YN/A
PM growth 3Y-13.11%
PM growth 5YN/A
GM growth 3Y-7.12%
GM growth 5YN/A
F-Score4
Asset Turnover1.7
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 53.94%
Cap/Sales 0.13%
Interest Coverage 4.55
Cash Conversion 68.8%
Profit Quality 87.36%
Current Ratio 0.86
Quick Ratio 0.86
Altman-Z 8.29
F-Score4
WACC10.16%
ROIC/WACC9.78
Cap/Depr(3y)23.44%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.09%
Cap/Sales(5y)N/A
Profit Quality(3y)117.51%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.64%
EPS 3Y-17.18%
EPS 5YN/A
EPS Q2Q%-38.9%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.07%
Revenue growth 3Y-4.68%
Revenue growth 5YN/A
Sales Q2Q%-4.26%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-33.54%
EBIT growth 3Y-16.02%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-58.5%
FCF growth 3Y-0.83%
FCF growth 5YN/A
OCF growth 1Y-58.19%
OCF growth 3Y-2.23%
OCF growth 5YN/A